Filed: 11/14/2022ACC: 0001012975-22-000490
📋 What this filing means
EUCLIDEAN CAPITAL LLC filed this quarterly 13F‑HR report disclosing 10 equity positions with a total reported market value of $107.7K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
10
Positions
$107.7K
Total AUM (reported)
18.64M
Total Shares
Allocation by class
COM$78.4K72.8%
CLASS A COM$29.3K27.2%
Portfolio Concentration
Top 3$67.9K63.1%
4–10$39.8K36.9%
Top 3 weight
63.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 18.64M
Sole
Full voting authority
18.64M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole10
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings10
Rows:
23ANDME HOLDING CO
SOLEShares10.24M
TypeSH
Market value$29.3K
27.20%
Sole
10.24M
Shared
0.00
None
0.00
PMV PHARMACEUTICALS INC
SOLEShares2.34M
TypeSH
Market value$27.8K
25.82%
Sole
2.34M
Shared
0.00
None
0.00
FOGHORN THERAPEUTICS INC
SOLEShares1.26M
TypeSH
Market value$10.8K
10.05%
Sole
1.26M
Shared
0.00
None
0.00
RAPT THERAPEUTICS INC
SOLEShares432.90K
TypeSH
Market value$10.4K
9.67%
Sole
432.90K
Shared
0.00
None
0.00
NGM BIOPHARMACEUTICALS INC
SOLEShares746.67K
TypeSH
Market value$9.8K
9.07%
Sole
746.67K
Shared
0.00
None
0.00
ALECTOR INC
SOLEShares980.89K
TypeSH
Market value$9.3K
8.61%
Sole
980.89K
Shared
0.00
None
0.00
FIRST FINL BANCORP OH
SOLEShares173.58K
TypeSH
Market value$3.7K
3.40%
Sole
173.58K
Shared
0.00
None
0.00
TENAYA THERAPEUTICS INC
SOLEShares915.71K
TypeSH
Market value$2.7K
2.47%
Sole
915.71K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares747.55K
TypeSH
Market value$2.4K
2.22%
Sole
747.55K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares802.96K
TypeSH
Market value$1.6K
1.51%
Sole
802.96K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
23ANDME HOLDING COSOLE | CLASS A COM | 10.24M | SH | $29.3K 27.20% | 10.24M | 0.00 | 0.00 |
PMV PHARMACEUTICALS INCSOLE | COM | 2.34M | SH | $27.8K 25.82% | 2.34M | 0.00 | 0.00 |
FOGHORN THERAPEUTICS INCSOLE | COM | 1.26M | SH | $10.8K 10.05% | 1.26M | 0.00 | 0.00 |
RAPT THERAPEUTICS INCSOLE | COM | 432.90K | SH | $10.4K 9.67% | 432.90K | 0.00 | 0.00 |
NGM BIOPHARMACEUTICALS INCSOLE | COM | 746.67K | SH | $9.8K 9.07% | 746.67K | 0.00 | 0.00 |
ALECTOR INCSOLE | COM | 980.89K | SH | $9.3K 8.61% | 980.89K | 0.00 | 0.00 |
FIRST FINL BANCORP OHSOLE | COM | 173.58K | SH | $3.7K 3.40% | 173.58K | 0.00 | 0.00 |
TENAYA THERAPEUTICS INCSOLE | COM | 915.71K | SH | $2.7K 2.47% | 915.71K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 747.55K | SH | $2.4K 2.22% | 747.55K | 0.00 | 0.00 |
SURROZEN INCSOLE | COM | 802.96K | SH | $1.6K 1.51% | 802.96K | 0.00 | 0.00 |